- Home
- LUCK vs OPK Comparison
LUCK vs OPK Comparison
Compare LUCK & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCK
- OPK
- Stock Information
- Founded
- LUCK 1997
- OPK 2007
- Country
- LUCK United States
- OPK United States
- Employees
- LUCK N/A
- OPK N/A
- Industry
- LUCK
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- LUCK
- OPK Health Care
- Exchange
- LUCK NYSE
- OPK Nasdaq
- Market Cap
- LUCK 1.3B
- OPK 1.1B
- IPO Year
- LUCK N/A
- OPK 1995
- Fundamental
- Price
- LUCK $10.41
- OPK $1.36
- Analyst Decision
- LUCK Strong Buy
- OPK Buy
- Analyst Count
- LUCK 3
- OPK 4
- Target Price
- LUCK $12.67
- OPK $2.75
- AVG Volume (30 Days)
- LUCK 288.7K
- OPK 2.6M
- Earning Date
- LUCK 09-04-2025
- OPK 08-06-2025
- Dividend Yield
- LUCK 2.11%
- OPK N/A
- EPS Growth
- LUCK N/A
- OPK N/A
- EPS
- LUCK N/A
- OPK N/A
- Revenue
- LUCK $1,184,019,000.00
- OPK $689,408,000.00
- Revenue This Year
- LUCK $5.49
- OPK N/A
- Revenue Next Year
- LUCK $5.67
- OPK $6.98
- P/E Ratio
- LUCK N/A
- OPK N/A
- Revenue Growth
- LUCK 6.65
- OPK N/A
- 52 Week Low
- LUCK $7.66
- OPK $1.21
- 52 Week High
- LUCK $13.25
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- LUCK N/A
- OPK 50.23
- Support Level
- LUCK N/A
- OPK $1.34
- Resistance Level
- LUCK N/A
- OPK $1.45
- Average True Range (ATR)
- LUCK 0.00
- OPK 0.05
- MACD
- LUCK 0.00
- OPK 0.00
- Stochastic Oscillator
- LUCK 0.00
- OPK 30.77
About LUCK LUCKY STRIKE ENTERTAINMENT CORPORAT
Lucky Strike Entertainment Corp is a entertainment platforms. It has nearly 360 locations across North America, that provides experiential offerings in bowling, amusements, water parks, and family entertainment centers. The company also owns the Professional Bowlers Association, the league of bowling and a growing media property.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.